{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:27:00Z","timestamp":1773491220410,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch Research Council (NWO) in the framework of the \u201cStartimpulse\u201d Dutch National Research Agenda (NWA)","award":["#400.17.604"],"award-info":[{"award-number":["#400.17.604"]}]},{"name":"Health Holland","award":["#20064"],"award-info":[{"award-number":["#20064"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>A malfunction of the innate immune response in COVID-19 is associated with eosinopenia, particularly in more severe cases. This study tested the hypothesis that this eosinopenia is COVID-19 specific and is associated with systemic activation of eosinophils. Blood of 15 healthy controls and 75 adult patients with suspected COVID-19 at the ER were included before PCR testing and analyzed by point-of-care automated flow cytometry (CD10, CD11b, CD16, and CD62L) in the absence or presence of a formyl peptide (fNLF). Forty-five SARS-CoV-2 PCR positive patients were grouped based on disease severity. PCR negative patients with proven bacterial (n = 20) or other viral (n = 10) infections were used as disease controls. Eosinophils were identified with the use of the FlowSOM algorithm. Low blood eosinophil numbers (&lt;100 cells\/\u03bcL; p &lt; 0.005) were found both in patients with COVID-19 and with other infectious diseases, albeit less pronounced. Two discrete eosinophil populations were identified in healthy controls both before and after activation with fNLF based on the expression of CD11b. Before activation, the CD11bbright population consisted of 5.4% (CI95% = 3.8, 13.4) of total eosinophils. After activation, this population of CD11bbright cells comprised nearly half the population (42.21%, CI95% = 35.9, 54.1). Eosinophils in COVID-19 had a similar percentage of CD11bbright cells before activation (7.6%, CI95% = 4.5, 13.6), but were clearly refractory to activation with fNLF as a much lower percentage of cells end up in the CD11bbright fraction after activation (23.7%, CI95% = 18.5, 27.6; p &lt; 0.001). Low eosinophil numbers in COVID-19 are associated with refractoriness in responsiveness to fNLF. This might be caused by migration of fully functional cells to the tissue.<\/jats:p>","DOI":"10.3390\/cells10051109","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T11:06:01Z","timestamp":1620212761000},"page":"1109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5636-6453","authenticated-orcid":false,"given":"Leo","family":"Koenderman","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.","family":"Siemers","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corneli","family":"van Aalst","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne H.","family":"Bongers","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Department of Trauma Surgery, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3620-5433","authenticated-orcid":false,"given":"Roy","family":"Spijkerman","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas J. J.","family":"Bindels","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Giustarini","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harri\u00ebt M. R.","family":"van Goor","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin A. H.","family":"Kaasjager","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke","family":"Vrisekoop","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"},{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: A rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"Leisman","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e57555","DOI":"10.7554\/eLife.57555","article-title":"Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome","volume":"9","author":"Netea","year":"2020","journal-title":"Elife"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e20200678","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13054-020-02911-9","article-title":"Acute respiratory failure in COVID-19: Is it \u201ctypical\u201d ARDS?","volume":"24","author":"Li","year":"2020","journal-title":"Crit. Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of Hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/JLB.5COVA0820-520RRR","article-title":"Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: A normal response to an abnormal situation","volume":"109","author":"Spijkerman","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"ref_10","first-page":"hcaa259","article-title":"EOSINOPENIA: An early, effective, and relevant COVID-19 biomarker?","volume":"2","author":"Roca","year":"2020","journal-title":"QJM"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., and Zhong, N.S. (2020). Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2002032"},{"key":"ref_12","unstructured":"World Health Organisation (WHO) (2010). International Statistical Classification of Diseases and Related Health Problems (International Classification of Diseases) (ICD) 10th Revision\u2014Version:2010, WHO Publications."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"112646","DOI":"10.1016\/j.jim.2019.112646","article-title":"Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes","volume":"474","author":"Spijkerman","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Callebaut","year":"2015","journal-title":"Cytom. Part A"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1515\/CCLM.2009.224","article-title":"Neutrophil CD64: A diagnostic marker for infection and sepsis","volume":"47","author":"Hoffmann","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_16","unstructured":"World Health Organization (2020, May 05). Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection is Suspected: Interim Guidance, 28 January 2020. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/330893."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"The ARDS Definition Task Force (2012). Acute Respiratory Distress Syndrome. JAMA, 307, 2526\u20132533.","DOI":"10.1001\/jama.2012.5669"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood.V70.2.379.379","article-title":"Eosinophils do respond to fMLP","volume":"70","author":"Yazdanbakhsh","year":"1987","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jlb.44.2.79","article-title":"An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals","volume":"44","author":"Koenderman","year":"1988","journal-title":"J. Leukoc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100078","DOI":"10.1016\/j.xcrm.2020.100078","article-title":"Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19","volume":"1","author":"Rodriguez","year":"2020","journal-title":"Cell Rep. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/JLB.1AB1219-493R","article-title":"Differentiation and activation of eosinophils in the human bone marrow during experimental human endotoxemia","volume":"108","author":"Hassani","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fmed.2017.00101","article-title":"Homeostatic Eosinophils: Characteristics and Functions","volume":"4","author":"Marichal","year":"2017","journal-title":"Front. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fmed.2017.00075","article-title":"Eosinophil Activation Status in Separate Compartments and Association with Asthma","volume":"4","author":"Johansson","year":"2017","journal-title":"Front. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2005.02.002","article-title":"Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge","volume":"115","author":"Luijk","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/iai.53.1.192-198.1986","article-title":"Bactericidal action of eosinophils from normal human blood","volume":"53","author":"Yazdanbakhsh","year":"1986","journal-title":"Infect Immun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.70.5.691","article-title":"Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens","volume":"70","author":"Rosenberg","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/all.13802","article-title":"Eosinophils capture viruses, a capacity that is defective in asthma","volume":"74","author":"Bal","year":"2019","journal-title":"Allergy"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0091-6749(86)90341-6","article-title":"The eosinophil and the pathophysiology of asthma","volume":"77","author":"Frigas","year":"1986","journal-title":"J Allergy Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/thx.2009.126722","article-title":"Effects of steroid therapy on inflammatory cell subtypes in asthma","volume":"65","author":"Cowan","year":"2010","journal-title":"Thorax"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/5\/1109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:57:13Z","timestamp":1760162233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/5\/1109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["cells10051109"],"URL":"https:\/\/doi.org\/10.3390\/cells10051109","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]}}}